Johnson & Johnson Says To Buy Pharma Group Actelion For $30 Bn

Johnson & Johnson says to buy pharma group Actelion for $30 bn

ZURICH, , (Pakistan Point News - APP - 26th Jan, 2017 ) - US pharmaceuticals giant Johnson & Johnson on Thursday announced it was buying Swiss medical firm Actelion for $30 billion (27.9 billion Euros). Johnson & Johnson's CEO and chairman Alex Gorsky said in a statement that the acquisition of Actelion, a leader in medicines treating high blood pressure, offered "compelling value" to shareholders in both companies.